Luis Miguel
Navarro Martín
Investigador desde 2019
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (13)
2024
-
Cáncer gástrico, de páncreas y de las vías biliares
Oncología clínica (Arán Ediciones), pp. 273-289
2019
-
Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma (European Radiology, (2019), 29, 4, (1968-1977), 10.1007/s00330-018-5758-7)
European Radiology
-
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma
European Radiology, Vol. 29, Núm. 4, pp. 1968-1977
2017
-
Glioblastoma: Pre-treatment geometry and texture of postcontrast T1 MRI matter
2016 Conference on Design of Circuits and Integrated Systems, DCIS 2016 - Proceedings
-
Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study
European Radiology, Vol. 27, Núm. 3, pp. 1096-1104
-
Plitidepsin: Design, development, and potential place in therapy
Drug Design, Development and Therapy, Vol. 11, pp. 253-264
2012
-
Tratamiento sistémico de la enfermedad metastásica
Revisiones en Cancer, Vol. 26, Núm. 1, pp. 33-44
2010
-
Severe, unilateral facial pain as the presenting manifestation of lung cancer
European Journal of Cancer Care
2008
-
New options in the treatment of locally advanced head and neck cancer: Role for induction chemotherapy
Cancer Treatment Reviews, Vol. 34, Núm. 3, pp. 268-274
-
Third nerve palsy as the initial presenting sign of metastatic prostate cancer
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 31, Núm. 4, pp. 407-408
2007
-
Tonic-clonic seizure as the presentation symptom of severe hypocalcemia secondary to zoledronic acid administration [1]
Journal of Palliative Medicine
2006
-
Patient with disseminated intravascular coagulation as the first manifestation of adenocarcinoma of the prostate. Risks of prostatic biopsy
Prostate Cancer and Prostatic Diseases, Vol. 9, Núm. 2, pp. 190-191
2005
-
Taponamiento cardíaco como forma de presentación de un tumor de origen desconocido: Abuso en las pruebas diagnósticas
Oncologia, Vol. 28, Núm. 6, pp. 39-42